General Information of Disease (ID: DIS1UU1B)

Disease Name Methamphetamine dependence
Disease Class 6C46: Stimulants use disorder
Definition A drug dependence that is a psychological dependency on the regular use of methamphetamine.
Disease Hierarchy
DIS9IXRC: Drug dependence
DIS1UU1B: Methamphetamine dependence
ICD Code
ICD-11
ICD-11: 6C46.2
ICD-10
ICD-10: F15.2
Disease Identifiers
MONDO ID
MONDO_0005419
UMLS CUI
C1533217
MedGen ID
735816
HPO ID
HP:0033519
SNOMED CT ID
426873000

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 6 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Armodafinil DMGB035 Approved Small molecular drug [1]
Atomoxetine DM5L6HI Approved Small molecular drug [2]
Ibudilast DM4LSPN Approved Small molecular drug [3]
Methamphetamine DMPM4SK Approved Small molecular drug [4]
Modafinil DMYILBE Approved Small molecular drug [5]
Quetiapine DM1N62C Approved Small molecular drug [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
METH-mab DMJHOKN Phase 1 Monoclonal antibody [7]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 6 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CSNK1E TTA8PLI Strong Genetic Variation [8]
GRIA3 TT82EZV Strong Genetic Variation [9]
MGAT1 TTYJRN5 Strong Genetic Variation [10]
NPY1R TTRK9JT Strong Genetic Variation [11]
PROKR2 TTM67AX Strong Biomarker [12]
SLC6A9 TTHJTF7 Strong Genetic Variation [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DTT(s)
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
FAAH DEUM1EX Limited Genetic Variation [13]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
GABBR1 OTU5A52J Strong Biomarker [14]
NAT8L OTA96AVN Strong Genetic Variation [15]
PROK2 OT70IFEZ Strong Biomarker [16]
TSNAX OTZ9SGWB Strong Biomarker [16]
------------------------------------------------------------------------------------

References

1 Armodafinil FDA Label
2 Atomoxetine FDA Label
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Methamphetamine FDA Label
5 Modafinil FDA Label
6 Quetiapine FDA Label
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036212)
8 Association study between casein kinase 1 epsilon gene and methamphetamine dependence.Ann N Y Acad Sci. 2008 Oct;1139:43-8. doi: 10.1196/annals.1432.025.
9 Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.J Psychopharmacol. 2018 Mar;32(3):309-315. doi: 10.1177/0269881117750153. Epub 2018 Jan 17.
10 The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147B(1):54-8. doi: 10.1002/ajmg.b.30565.
11 Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. Psychiatry Clin Neurosci. 2009 Jun;63(3):417-22. doi: 10.1111/j.1440-1819.2009.01961.x.
12 PROKR2 is associated with methamphetamine dependence in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1033-6. doi: 10.1016/j.pnpbp.2010.05.018. Epub 2010 May 24.
13 FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence.Ann Hum Genet. 2020 May;84(3):259-270. doi: 10.1111/ahg.12368. Epub 2019 Dec 2.
14 Variants in GABBR1 Gene Are Associated with Methamphetamine Dependence and Two Years' Relapse after Drug Rehabilitation.J Neuroimmune Pharmacol. 2018 Dec;13(4):523-531. doi: 10.1007/s11481-018-9802-9. Epub 2018 Aug 24.
15 Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate.Behav Brain Res. 2018 Feb 26;339:207-214. doi: 10.1016/j.bbr.2017.11.040. Epub 2017 Dec 2.
16 Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1618-22. doi: 10.1016/j.pnpbp.2011.06.001. Epub 2011 Jun 13.